ArticleThe European respiratory journal2022

Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of systemic sclerosis-associated interstitial lung disease.

Anna Birnhuber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.